US FDA Oncology Center Makes Dose Optimization Personal

‘Project Optimus’ is continuing to press forward on reframing the approach to dosing of anticancer drugs. The initiative is very personal to OCE Director Richard Pazdur.

More from Clinical Trials

More from R&D